Martin Whitman - Third Avenue Management
Holding/activity history for ANI Pharmaceuticals Inc. (ANIP)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2017 Q3 | 0 | 0.00 | Sell 100.00% | 0.11 | SEC | ||
| 2017 Q2 | 49,933 | 0.11 | $46.80 | $2,337,000 | SEC | ||
| 2017 Q1 | 49,933 | 0.11 | $49.51 | $2,472,000 | SEC | ||
| 2016 Q4 | 49,933 | 0.14 | Reduce 0.24% | <0.01 | $60.62 | $3,027,000 | SEC |
| 2016 Q3 | 50,053 | 0.16 | $66.35 | $3,321,000 | SEC | ||
| 2016 Q2 | 50,053 | 0.13 | $55.82 | $2,794,000 | SEC | ||
| 2016 Q1 | 50,053 | 0.07 | $33.66 | $1,685,000 | SEC | ||
| 2015 Q4 | 50,053 | 0.08 | Reduce 16.18% | 0.01 | $45.13 | $2,259,000 | SEC |
| 2015 Q3 | 59,716 | 0.07 | Add 15.30% | <0.01 | $39.50 | $2,359,000 | SEC |
| 2015 Q2 | 51,790 | 0.08 | Buy | 0.08 | $62.06 | $3,214,000 | SEC |